CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31
Cannabis Bioscience International Holdings, Inc.
Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Apr 16, 2026
$0.00+0.00 (+33.33%)
Close on Oct 19, 2026
- Market cap
- $2.33M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0003 (−60.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Cannabis Bioscience International Holdings, Inc. saw revenue fall 64.1% to $123.63K over the twelve months to Feb 28, 2026.
Revenue
$123.63K
-64.1% vs. a year earlier
Operating income
-$398.82K
TTM Q3 2026
EPS, diluted
-$0.00
TTM Q3 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Feb 28, 2026
Valuation
- Market cap
- $2.33M
- P/E ratio
- –
- Price to sales
- 18.81
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $123.63K
- Net income
- -$515.29K
- EPS, diluted
- -$0.00
- Book value per share
- -$0.00
- Diluted shares
- 11.63B
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
$123.63K-64.1% YoY
Gross profit
$97.39K-67.4% YoY
Operating income
-$398.82K
Net income
-$515.29K
EPS, diluted
-$0.00
Reported periodTrailing twelve months